Clincosm LogoSign in Get a demo

Renal Cancer

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cancer Trial in Milan (Radical or partial nephrectomy)

Recruiting
  • Renal Cancer
  • Radical or partial nephrectomy
  • Milan, MI, Italy
    IRCCS Ospedale San Raffaele
Nov 23, 2023

Renal Cancer Trial in Aarhus N

Enrolling by invitation
  • Renal Cancer
    • Aarhus N, Denmark
      Urology Department Aarhus University Hospital
    Nov 21, 2023

    Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)

    Recruiting
    • Renal Cancer
    • Magnetic Resonance Imaging (MRI) Scan
    • Tc-99m Pentetate
    • New York, New York
      NYU Langone Health
    Oct 31, 2023

    Prostate Cancer, Renal Cancer, Urologic Diseases Trial in Seoul (BP management with HPI guidance)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • BP management with HPI guidance
    • Seoul, Korea, Republic of
      Ewha Womans University Mokdong Hospital
    Sep 17, 2023

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Copper-64 labeled Granzyme B (64Cu-GRIP B)
    • Positron Emission Tomography (PET)
    • San Francisco, California
      University of California, San Francisco
    Jun 7, 2023

    Kidney Cancer, Renal Cancer, Renal Tumor Trial in Miami (Ketorolac, Acetaminophen, Oxycodone)

    Not yet recruiting
    • Kidney Cancer
    • +2 more
    • Miami, Florida
      University of Miami
    Apr 24, 2023

    Complications in Patients Who Underwent LPN According to the CCI

    Completed
    • Renal Cancer
    • Surgery-Complications
      • Samsun, Turkey
        Ondokuz Mayıs University, Department of Urology
      Apr 21, 2023

      Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)

      Not yet recruiting
      • Renal Cancer
      • +4 more
      • HistoSonics Edison System
      • (no location specified)
      Apr 18, 2023

      Stereotactic Body Radiotherapy for Medically Inoperable

      Recruiting
      • Kidney Neoplasm
      • +2 more
      • SBRT
      • Terrassa, Barcelona, Spain
        Consorci Sanitari de Terrassa
      Apr 5, 2023

      Wilms Tumor, Renal Cancer Trial in Birmingham (Indocyanine Green (ICG))

      Not yet recruiting
      • Wilms Tumor
      • Renal Cancer
      • Indocyanine Green (ICG)
      • Birmingham, United Kingdom
        Birmingham children's hospital
      Feb 9, 2023

      Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

      Active, not recruiting
      Has Results
      • Renal Cancer
      • Dendritic Cell Tumor Fusion Vaccine
      • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jan 2, 2023

      Serum and Tissue Samples From Biopsy-Proved or Suspected

      Recruiting
      • Malignant Neoplasms
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

        Recruiting
        • Renal Cancer
        • +2 more
          • Amsterdam, Noord Holland, Netherlands
            Amsterdam UMC locatie VUMC
          Jan 20, 2023

          Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

          Active, not recruiting
          • Melanoma
          • +7 more
          • Scottsdale, Arizona
          • +36 more
          Dec 22, 2022

          Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

          Recruiting
          • Metastatic Cancer
          • +5 more
          • Stereotactic Body Radiotherapy
          • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
          • Hartford, Connecticut
          • +9 more
          Nov 17, 2022

          Validation for Early Cancer Detection and Minimal Residual

          Recruiting
          • Brain Cancer
          • +19 more
            • Duarte, California
            • +6 more
            Nov 10, 2022

            Kidney Tumor, Renal Cancer Trial in New York (Decision Aid (DA) Web Tool, Institutional Pamphlet)

            Recruiting
            • Kidney Tumor
            • Renal Cancer
            • Decision Aid (DA) Web Tool
            • Institutional Pamphlet
            • New York, New York
              NYU Langone Health
            Nov 4, 2022

            Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

            Suspended
            • Metastatic Cancer
            • Renal Cancer
            • Indianapolis, Indiana
            • +3 more
            Oct 29, 2022

            Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

            Recruiting
            • Genetic Testing
            • +8 more
            • Video Education
            • Genetic Counseling
            • Boston, Massachusetts
              Dana Farber Cancer Institute
            Oct 31, 2022

            Nivolumab in Recurring Kidney Cancer Participants

            Completed
            • Kidney Cancer
            • Renal Cancer
            • Non-Interventional
            • Tokyo, Japan
              Local Institution - 0001
            Oct 19, 2022

            ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

            Recruiting
            • ccRCC
            • +9 more
            • Oral NKT2152
            • Scottsdale, Arizona
            • +6 more
            Oct 17, 2022

            Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

            Completed
            Has Results
            • Renal Cell Carcinoma
            • +3 more
            • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
            • New York, New York
              Memorial Sloan-Kettering Cancer Center
            Oct 3, 2022

            Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

            Completed
            Has Results
            • Cancer of Kidney
            • +6 more
            • 124-Iodine-cG250 (124I-cG250)
            • New York, New York
              Memorial Sloan-Kettering Cancer Center
            Oct 3, 2022